Highlights
NASDAQ: AMPE       Ampio Pharmaceuticals
Last Price Today's Change   Day's Range   Trading Volume
0.613   0.00 (0.00%)  0.00 - 0.00  0

Overview

 
Avg Volume (4 weeks):4,332,163
4 Weeks Range:0.454 - 0.85
4 Weeks Price Volatility (%):
72.12%
52 Weeks Range:0.26 - 0.91
52 Weeks Price Volatility (%):
67.36%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Ampio Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused primarily on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options. The Company's two lead product candidates in development are Ampion for osteoarthritis of the knee and Optina for diabetic macular edema. Ampion is a sub 5000 molecular weight fraction of commercial human serum albumin (HSA). Optina is a low-dose formulation of danazol. The Ampio segment consists of its biopharmaceuticals compounds and the clinical trials associated with them. The Company is primarily developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and at the transcription level; activating specific phosphatase or depleting available phosphate needed for the inflammation process, and decreasing vascular permeability.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

2247  3565  257  2995 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 GNUS 3.455+1.145 
 NIO 9.21+1.30 
 LK 1.38-1.62 
 SOLO 3.37+1.04 
 WKHS 20.88+1.70 
 AAL 12.62-0.19 
 AVP 5.60-0.05 
 SQQQ 7.02-0.27 
 PCG 9.565+0.535 
 GE 6.865+0.125 
Partners & Brokers